Skip to main content

Advertisement

SpringerLink
Log in

Management of skeletal metastases: An orthopaedic surgeon’s guide

  • Symposium-ICL-2014
  • Published:
Indian Journal of Orthopaedics Aims and scope Submit manuscript

Abstract

Skeletal metastasis is a common cause of severe morbidity, reduction in quality of life (QOL) and often early mortality. Its prevalence is rising due to a higher rate of diagnosis, better systemic treatment, longer lives with the disease and higher disease burden rate. As people with cancer live longer and with rising sensitivity of body imaging and surveillance, the incidence of pathological fracture, metastatic epidural cord compression is rising and constitutes a challenge for the orthopedic surgeon to maintain their QOL. Metastatic disease is no longer a death sentence condemning patients to “terminal care.” In the era of multidisciplinary care and effective systemic targeted and nontargeted therapy, patient expectations of QOL, even during palliative end of care period is high. We lay emphasis on proving the diagnosis of metastasis by biopsy and histopathology and discuss imaging modalities to help estimate fracture risk and map disease extent. This article discusses at length the evidence and decision-making process of various modalities to treat skeletal metastasis. The modalities range from radiation including image-guided, stereotactic and whole body radiation, systemic targeted or hormonal therapy, spinal decompression with or without stabilization, extended curettage with stabilization, resection in select cases with megaprosthetic or biological reconstruction, percutaneous procedures using radio frequency ablation, cementoplasties and discusses the role of emerging modalities like high frequency ultrasound-guided ablation, cryotherapy and whole body radionuclide therapy. The focus lies on the role of multidisciplinary care, which considers complex decisions on patient centric prognosis, comorbidities, cost, feasibility and expectations in order to maximize outcomes on QOL issues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rubens RD, Mundy GR. Cancer and the Skeleton. London (UK): Martin Dunitz; 2000.

    Google Scholar 

  2. Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase iii, double-blind, randomized trial-The zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol 2003;21:3150–7.

    Article  PubMed  CAS  Google Scholar 

  3. Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, et al. Long term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: A randomized, double-blind, multicenter, comparative trial. Cancer 2003;98:1735–44.

    Article  PubMed  CAS  Google Scholar 

  4. Aaron AD. Current concepts review-treatment of metastatic adenocarcinoma of the pelvis and the extremities*. J Bone Joint Surg 1997;79:917–32.

    Article  PubMed  CAS  Google Scholar 

  5. Harrington KD. Orthopaedic management of extremity and pelvic lesions. Clin Orthop Relat Res 1995:136–47.

    Google Scholar 

  6. Theriault RL. Biology of bone metastases. Cancer Control J Moffitt Cancer Cent 2012;19:92–101.

    Article  Google Scholar 

  7. Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. J Nucl Med 2005;46:1356–67.

    PubMed  Google Scholar 

  8. Rosenthal DI. Radiologic diagnosis of bone metastases. Cancer 1997;80 8 Suppl:1595–607.

    Article  PubMed  CAS  Google Scholar 

  9. Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu TK, et al. Imaging bone metastases in breast cancer: Techniques and recommendations for diagnosis. Lancet Oncol 2009;10:606–14.

    Article  PubMed  Google Scholar 

  10. Fidler M. Prophylactic internal fixation of secondary neoplastic deposits in long bones. Br Med J 1973;1:341–3.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Harrington KD. New trends in the management of lower extremity metastases. Clin Orthop Relat Res 1982:53–61.

    Google Scholar 

  12. Damron TA, Morgan H, Prakash D, Grant W, Aronowitz J, Heiner J. Critical evaluation of Mirels’ rating system for impending pathologic fractures. Clin Orthop Relat Res 2003:S201–7.

    Google Scholar 

  13. Evans AR, Bottros J, Grant W, Chen BY, Damron TA. Mirels’ rating for humerus lesions is both reproducible and valid. Clin Orthop Relat Res 2008;466:1279–84.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Van der Linden YM, Dijkstra PD, Kroon HM, Lok JJ, Noordijk EM, Leer JW, et al. Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br 2004;86:566–73.

    Article  PubMed  Google Scholar 

  15. Leong NL, Anderson ME, Gebhardt MC, Snyder BD. Computed tomography-based structural analysis for predicting fracture risk in children with benign skeletal neoplasms: Comparison of specificity with that of plain radiographs. J Bone Joint Surg Am 2010;92:1827–33.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hong J, Cabe GD, Tedrow JR, Hipp JA, Snyder BD. Failure of trabecular bone with simulated lytic defects can be predicted non-invasively by structural analysis. J Orthop Res 2004;22:479–86.

    Article  PubMed  Google Scholar 

  17. Keyak JH, Kaneko TS, Rossi SA, Pejcic MR, Tehranzadeh J, Skinner HB. Predicting the strength of femoral shafts with and without metastatic lesions. Clin Orthop Relat Res 2005;439:161–70.

    Article  PubMed  Google Scholar 

  18. Ludwig H, Kumpan W, Sinzinger H. Radiography and bone scintigraphy in multiple myeloma: A comparative analysis. Radiography 1982;55:173–81.

    CAS  Google Scholar 

  19. Woolfenden JM, Pitt MJ, Durie BG, Moon TE. Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 1980;134:723–8.

    Article  PubMed  CAS  Google Scholar 

  20. Resnick DL. Diagnosis of Bone and Joint Disorders. Philadelphia: WB Saunders; 2002.

    Google Scholar 

  21. Rybak LD, Rosenthal DI. Radiological imaging for the diagnosis of bone metastases. Q J Nucl Med 2001;45:53–64.

    PubMed  CAS  Google Scholar 

  22. Ryan PJ, Fogelman I. The bone scan: Where are we now?. Semin Nucl Med 1995;25:76–91.

    Article  PubMed  CAS  Google Scholar 

  23. Savelli G, Maffioli L, Maccauro M, De Deckere E, Bombardieri E. Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions. Q J Nucl Med 2001;45:27–37.

    PubMed  CAS  Google Scholar 

  24. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF. Comparison and discrepancy of 18f-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 1999;20:2189–92.

    Google Scholar 

  25. Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the followup of patients with breast carcinoma: A comparison to conventional imaging. Invest Radiol 2003;38:250–6.

    PubMed  Google Scholar 

  26. Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005;35:135–42.

    Article  PubMed  Google Scholar 

  27. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: Applying new technology to an old tracer. J Nucl Med 2008;49:68–78.

    Article  PubMed  Google Scholar 

  28. Sapir EE, Mishani E, Flusser G, Ur M. 18f-fluoride positron emission tomography and positron emission tomography/ computed tomography. Semin Nucl Med 2007;37:462–9.

    Article  Google Scholar 

  29. Hetzel M, Arslandemir C, König HH, Buck AK, Nüssle K, Glatting G, et al. F-18 NaF PET for detection of bone metastases in lung cancer: Accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res 2003;18:2206–14.

    Article  PubMed  Google Scholar 

  30. Ball AB, Fisher C, Pittam M, Watkins RM, Westbury G. Diagnosis of soft tissue tumours by tru-Cut biopsy. Br J Surg 1990;77:756–8.

    Article  PubMed  CAS  Google Scholar 

  31. Kissin MW, Fisher C, Carter RL, Horton LW, Westbury G. Value of tru-cut biopsy in the diagnosis of soft tissue tumours. Br J Surg 1986;73:742–4.

    Article  CAS  PubMed  Google Scholar 

  32. Pramesh CS, Deshpande MS, Pardiwala DN, Agarwal MG, Puri A. Core needle biopsy for bone tumours. Eur J Surg Oncol 2001;27:668–71.

    Article  PubMed  CAS  Google Scholar 

  33. Briasoulis E, Pavlidis N, Felip E, ESMO Guidelines Working Group. Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and followup. Ann Oncol 2009;20 Suppl 4:154–5.

    Article  PubMed  Google Scholar 

  34. Lipton A. Implications of bone metastases and the benefits of bone-targeted therapy. Semin Oncol 2010;37:S15-29.

  35. Berenson JR, Lichtenstein A, L, Dimopoulos MA, Bordoni R, George S, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 1996;334:488–93.

    Article  PubMed  CAS  Google Scholar 

  36. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 1996;335:1785–92.

    Article  PubMed  CAS  Google Scholar 

  37. Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: A review of 2,400 patient cases. J Cancer Res Clin Oncol 2010;136:1117–24.

    Article  PubMed  CAS  Google Scholar 

  38. Palaska PK, Cartsos V, Zavras AI. Bisphosphonates and time to osteonecrosis development. Oncologist 2009;14:1154–66.

    Article  PubMed  CAS  Google Scholar 

  39. Fehm T, Felsenberg D, Krimmel M, Solomayer E, Wallwiener D, Hadjii P. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatment. Breast 2009;18:213–7.

    Article  PubMed  CAS  Google Scholar 

  40. Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study. J Clin Oncol 2010;28:5132–9.

    Article  PubMed  CAS  Google Scholar 

  41. Lutz S, Berk L, Chang E, Chow E, Hahn C, Hoskin P, et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;79:965–76.

    Article  PubMed  Google Scholar 

  42. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T, Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594–605.

    Article  PubMed  Google Scholar 

  43. Sze WM, Shelley MD, Held I, Wilt TJ, Mason MD. Palliation of metastatic bone pain: Single fraction versus multifraction radiotherapy - A systematic review of randomised trials. Clin Oncol (R Coll Radiol) 2003;15:345–52.

    Article  CAS  Google Scholar 

  44. Roqué I, Figuls M, Martinez-Zapata MJ, Coello PA, Català E, Garcia JL, Ferrandiz M. Radioisotopes for metastatic bone pain. Cochrane Libr 2003.

    Google Scholar 

  45. Dupuy DE, Hong R, Oliver B, Goldberg SN. Radiofrequency ablation of spinal tumors: Temperature distribution in the spinal canal. AJR Am J Roentgenol 2000;175:1263–6.

    Article  PubMed  CAS  Google Scholar 

  46. Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP, Welch TJ, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study. J Clin Oncol 2004;22:300–6.

    Article  PubMed  Google Scholar 

  47. Dupuy DE, Liu D, Hartfeil D, Hanna L, Blume JD, Ahrar K, et al. Percutaneous radiofrequency ablation of painful osseous metastases: A multicenter American College of Radiology Imaging Network trial. Cancer 2010;116:989–97.

    Article  PubMed  Google Scholar 

  48. Marcy PY, Palussière J, Descamps B, Magné N, Bondiau PY, Ciais C, et al. Percutaneous cementoplasty for pelvic bone metastasis. Support Care Cancer 2000;8:500–3.

    Article  PubMed  CAS  Google Scholar 

  49. Hoffmann RT, Jakobs TF, Trumm C, Weber C, Helmberger TK, Reiser MF. Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease. J Vasc Interv Radiol 2008;19:419–25.

    Article  PubMed  Google Scholar 

  50. Callstrom MR, Atwell TD, Charboneau JW, Farrell MA, Goetz MP, Rubin J, et al. Painful metastases involving bone: Percutaneous image-guided cryoablation - Prospective trial interim analysis. Radiology 2006;241:572–80.

    Article  PubMed  Google Scholar 

  51. Callstrom MR, Dupuy DE, Solomon SB, Beres RA, Littrup PJ, Davis KW, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: Multicenter trial. Cancer 2013;119:1033–41.

    Article  PubMed  Google Scholar 

  52. Li C, Zhang W, Fan W, Huang J, Zhang F, Wu P. Noninvasive treatment of malignant bone tumors using high-intensity focused ultrasound. Cancer 2010;116:3934–42.

    Article  PubMed  Google Scholar 

  53. Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results. J Natl Cancer Inst 2014;106.

    Google Scholar 

  54. Catane R, Beck A, Inbar Y, Rabin T, Shabshin N, Hengst S, et al. MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases - Preliminary clinical experience. Ann Oncol 2007;18:163–7.

    Article  PubMed  CAS  Google Scholar 

  55. Gianfelice D, Gupta C, Kucharczyk W, Bret P, Havill D, Clemons M. Palliative treatment of painful bone metastases with MR imaging - Guided focused ultrasound. Radiology 2008;249:355–63.

    Article  PubMed  Google Scholar 

  56. Liberman B, Gianfelice D, Inbar Y, Beck A, Rabin T, Shabshin N, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: A multicenter study. Ann Surg Oncol 2009;16:140–6.

    Article  PubMed  Google Scholar 

  57. Kastler A, Alnassan H, Aubry S, Kastler B. Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol 2014;25:1470–5.

    Article  PubMed  Google Scholar 

  58. Filippiadis DK, Tutton S, Mazioti A, Kelekis A. Percutaneous image-guided ablation of bone and soft tissue tumours: A review of available techniques and protective measures. Insights Imaging 2014;5:339–46.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Pusceddu C, Sotgia B, Fele RM, Melis L. Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol 2013;24:229–33.

    Article  PubMed  Google Scholar 

  60. Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: Principles and applications. Radiographics 2005;25 Suppl 1:S69–83.

    Article  PubMed  Google Scholar 

  61. Nierman E, Zakrzewski K. Recognition and management of preoperative risk. Rheum Dis Clin North Am 1999;25:585–622.

    Article  PubMed  CAS  Google Scholar 

  62. Houston MC, Ratcliff DG, Hays JT, Gluck FW. Preoperative medical consultation and evaluation of surgical risk. South Med J 1987;80:1385–97.

    Article  PubMed  CAS  Google Scholar 

  63. Wolfe BM, Phillips GJ, Hodges RE. Evaluation and management of nutritional status before surgery. Med Clin North Am 1979;63:1257–69.

    Article  PubMed  CAS  Google Scholar 

  64. Coleman RE. Skeletal complications of malignancy. Cancer 1997;80 8 Suppl:1588–94.

    Article  PubMed  CAS  Google Scholar 

  65. Ewer MS, Ali MK. Surgical treatment of the cancer patient: Preoperative assessment and perioperative medical management. J Surg Oncol 1990;44:185–90.

    Article  PubMed  CAS  Google Scholar 

  66. Barwood SA, Wilson JL, Molnar RR, Choong PF. The incidence of acute cardiorespiratory and vascular dysfunction following intramedullary nail fixation of femoral metastasis. Acta Orthop 2000;71:147–52.

    Article  CAS  Google Scholar 

  67. Choong PF. Cardiopulmonary complications of intramedullary fixation of long bone metastases. Clin Orthop Relat Res 2003:S245–53.

    Google Scholar 

  68. Pietak S, Holmes J, Matthews R, Petrasek A, Porter B. Cardiovascular collapse after femoral prosthesis surgery for acute hip fracture. Can J Anaesth 1997;44:198–201.

    Article  PubMed  CAS  Google Scholar 

  69. Duncan JA. Intra-operative collapse or death related to the use of acrylic cement in hip surgery. Anaesthesia 1989;44:149–53.

    Article  PubMed  CAS  Google Scholar 

  70. Byrick RJ, Bell RS, Kay JC, Waddell JP, Mullen JB. High-volume, high-pressure pulsatile lavage during cemented arthroplasty. J Bone Joint Surg Am 1989;71:1331–6.

    Article  PubMed  CAS  Google Scholar 

  71. Sherman RM, Byrick RJ, Kay JC, Sullivan TR, Waddell JP. The role of lavage in preventing hemodynamic and blood-gas changes during cemented arthroplasty. J Bone Joint Surg Am 1983;65:500–6.

    Article  PubMed  CAS  Google Scholar 

  72. Wheelwright EF, Byrick RJ, Wigglesworth DF, Kay JC, Wong PY, Mullen JB, et al. Hypotension during cemented arthroplasty. Relationship to cardiac output and fat embolism. J Bone Joint Surg Br 1993;75:715–23.

    Article  PubMed  CAS  Google Scholar 

  73. Müller C, McIff T, Rahn BA, Pfister U, Weller S. Intramedullary pressure, strain on the diaphysis and increase in cortical temperature when reaming the femoral medullary cavity - A comparison of blunt and sharp reamers. Injury 1993;24 Supp 13:S22–30.

    Article  PubMed  Google Scholar 

  74. Martin R, Leighton RK, Petrie D, Ikejiani C, Smyth B. Effect of proximal and distal venting during intramedullary nailing. Clin Orthop Relat Res 1996:80–9.

    Google Scholar 

  75. Molloy WD, Lee KY, Girling L, Schick U, Prewitt RM. Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 1984;130:870–4.

    PubMed  CAS  Google Scholar 

  76. Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: Hemodynamic and biochemical correlations. Circulation 1981;63:87–95.

    Article  PubMed  CAS  Google Scholar 

  77. Galasko CS. Incidence and distribution of bone metastases. Clin Orthop 1986;210:14–21.

    Google Scholar 

  78. Posner JB. editor. Neurologic complications of cancer. Vol. 45. Philadelphia: FA Davis Company; 1995.

  79. Laufer I, Sciubba DM, Madera M, Bydon A, Witham TJ, Gokaslan ZL, et al. Surgical management of metastatic spinal tumors. Cancer Control 2012;19:122–8.

    Article  PubMed  CAS  Google Scholar 

  80. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro Oncol 2005;7:64–76.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. Lancet 2005;366:643–8.

    Article  PubMed  Google Scholar 

  82. Bilsky MH, Laufer I, Burch S. Shifting paradigms in the treatment of metastatic spine disease. Spine (Phila Pa 1976) 2009;34:S101-7.

  83. George R, Jeba J, Ramkumar G, Chacko AG, Leng M, Tharyan P. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev 2008:CD006716.

    Google Scholar 

  84. Wang JC, Boland P, Mitra N, Yamada Y, Lis E, Stubblefield M, et al. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: Results in 140 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004;1:287–98.

    PubMed  Google Scholar 

  85. Rades D, Huttenlocher S, Evers JN, Bajrovic A, Karstens JH, Rudat V, et al. Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression? Strahlenther Onkol 2012;188:424–30.

    Article  PubMed  CAS  Google Scholar 

  86. Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 2010;28:3597–604.

    Article  PubMed  Google Scholar 

  87. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976). 2001;26:298–306.

    Article  CAS  Google Scholar 

  88. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30:2186–91.

    Article  Google Scholar 

  89. Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028–37.

    Article  PubMed  Google Scholar 

  90. Ahn SG, Lee HM, Cho SH, Lee SA, Hwang SH, Jeong J, et al. Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J 2013;54:1168–77.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Niikura N, Liu J, Hayashi N, Palla SL, Tokuda Y, Hortobagyi GN, et al. Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: A single-institution retrospective analysis. Oncologist 2011;16:155–64.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Baloch KG, Grimer RJ, Carter SR, Tillman RM. Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br 2000;82:62–7.

    Article  PubMed  CAS  Google Scholar 

  93. Hirano Y, Oda M, Tsunezuka Y, Ishikawa N, Watanabe G. Long term survival cases of lung cancer presented as solitary bone metastasis. Ann Thorac Cardiovasc Surg 2005;11:401–4.

    PubMed  Google Scholar 

  94. Fuchs B, Trousdale RT, Rock MG. Solitary bony metastasis from renal cell carcinoma: Significance of surgical treatment. Clin Orthop Relat Res 2005:187–92.

    Google Scholar 

  95. Fottner A, Szalantzy M, Wirthmann L, Stähler M, Baur-Melnyk A, Jansson V, et al. Bone metastases from renal cell carcinoma: Patient survival after surgical treatment. BMC Musculoskelet Disord 2010;11:145.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Weber KL, O’Connor MI. Operative treatment of long bone metastases: Focus on the femur. Clin Orthop Relat Res 2003:S276–8.

    Google Scholar 

  97. Gainor BJ, Buchert P. Fracture healing in metastatic bone disease. Clin Orthop Relat Res 1983:297–302.

    Google Scholar 

  98. Harrington KD. The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 1981;63:653–64.

    Article  PubMed  CAS  Google Scholar 

  99. Johnson JT. Reconstruction of the pelvic ring following tumor resection. J Bone Joint Surg Am 1978;60:747–51.

    Article  PubMed  CAS  Google Scholar 

  100. Damron TA, Sim FH. Operative treatment for metastatic disease of the pelvis and the proximal end of the femur. J Bone Joint Surg Am 2000;82:114–26.

    Google Scholar 

  101. Satcher Jr RL, O’Donnell RJ, Johnston JO. Reconstruction of the pelvis after resection of tumors about the acetabulum. Clin Orthop Relat Res 2003:209–17.

    Google Scholar 

  102. Marco RA, Sheth DS, Boland PJ, Wunder JS, Siegel JA, Healey JH. Functional and oncological outcome of acetabular reconstruction for the treatment of metastatic disease. J Bone Joint Surg Am 2000;82:642–51.

    Article  PubMed  CAS  Google Scholar 

  103. Clarke HD, Damron TA, Sim FH. Head and neck replacement endoprosthesis for pathologic proximal femoral lesions. Clin Orthop Relat Res 1998:210–7.

    Google Scholar 

  104. Morris HG, Capanna R, Del Ben M, Campanacci D. Prosthetic reconstruction of the proximal femur after resection for bone tumors. J Arthroplasty 1995;10:293–9.

    Article  PubMed  CAS  Google Scholar 

  105. Herrenbruck T, Erickson EW, Damron TA, Heiner J. Adverse clinical events during cemented long-stem femoral arthroplasty. Clin Orthop Relat Res 2002:154–63.

    Google Scholar 

  106. Patterson BM, Healey JH, Cornell CN, Sharrock NE. Cardiac arrest during hip arthroplasty with a cemented long-stem component. A report of seven cases. J Bone Joint Surg Am 1991;73:271–7.

    Article  PubMed  CAS  Google Scholar 

  107. Wedin R, Bauer HC. Surgical treatment of skeletal metastatic lesions of the proximal femur endoprosthesis or reconstruction nail? J Bone Joint Surg Br 2005;87:1653–57.

    Article  PubMed  CAS  Google Scholar 

  108. Frankel VH, Burstein AH. Orthopaedic biomechanics: The application of engineering to the musculoskeletal system. Philadelphia: Lea and Febiger; 1970.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. P.D. Hinduja National Hospital, Veer Savarkar Marg, Mahim, Ullas, 1st Floor, 17, Laburnum Road, Gamdevi, Mumbai, 400 007, Maharashtra, India

    Manish G. Agarwal & Prakash Nayak

Authors
  1. Manish G. Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prakash Nayak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manish G. Agarwal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agarwal, M.G., Nayak, P. Management of skeletal metastases: An orthopaedic surgeon’s guide. IJOO 49, 83–100 (2015). https://doi.org/10.4103/0019-5413.143915

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/0019-5413.143915

Key words

MeSH terms

Search

Navigation